USFDA concerns hit Lupin; stock tanks 6%
Lupin shares succumbed to extreme selling pressure after reports emerged that the company received Form 483 for its Mandideep plant in Goa from the US Drug and Food Agency (USFDA). The stock closed lower by 6.27 per cent.
Other Stocks Videos
Biocon to sell stake in biosimilar arm and Syngene: Sources
Stocks in news: Lupin, GMR Airports and more
Stocks in news: United Breweries, Tata Motors, Mazagon Dock and more
Manipal's Ranjan Pai acquires Rs 1,400 crore Davidson Kempner debt on BYJU's
Samvat 2080: 80 stock recommendations from top brokerage houses for your portfolio this new year
